Interleukin-10 (IL-10) counterregulates IL-4-dependent effector mechanisms in murine filariasis

被引:47
|
作者
Specht, S
Volkmann, L
Wynn, T
Hoerauf, A
机构
[1] Univ Bonn, Inst Med Parasitol, D-53105 Bonn, Germany
[2] Bernhard Nocht Inst Trop Med, Dept Helminthol, Hamburg, Germany
[3] NIAID, Immunol Sect, Lab Parasit Dis, Natl Inst Hlth, Bethesda, MD 20892 USA
关键词
D O I
10.1128/IAI.72.11.6287-6293.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-10 (IL-10) was at first described as a Th2-associated cytokine, although more recent reports have shown that immunosuppression applies to both Th1 and Th2 cell responses, e.g., when produced by T regulatory cells. This concept when applied to human filariasis would argue that high parasite loads are associated with IL-10, while bona fide Th2 responses, mediated by IL-4, IL-5, and IL-13, are associated with parasite containment. To prove this relationship in causal manner, we investigated the roles of IL-4 and IL-10 in a helminth infection model in which mice genetically deficient for IL-4, IL-10, or IL-4 plus IL-10 were infected with the rodent filaria Litomosoides sigmodontis. Compared to C57BL/6 wild-type and IL-10 knockout (KO) mice, IL-4 KO mice remained susceptible, exhibiting a remarkable number of live adult worms. Interestingly however, when the IL-10 gene was knocked out simultaneously with the IL-4 gene, the susceptibility of IL-4 KO mice was reversed. Although production of IFN-gamma was increased in IL-4/IL-10 double-knockout mice, depletion of gamma interferon did not affect worm elimination, so it seems unlikely to be the major factor in mediating resistance in IL-4/IL-10 KO mice. Taken together, the results of this study add proof to the concept that has arisen for human filariasis that IL-10-dependent responses, which are associated with patency, are antagonistic to bona fide Th2 responses, which control parasite loads. The finding that knockout of IL-10 reversed a disease phenotype induced by knockout of IL-4 gives the first causal evidence of an antagonistic activity between IL-4 and IL-10 in an infection in vivo.
引用
收藏
页码:6287 / 6293
页数:7
相关论文
共 50 条
  • [41] INTERLEUKIN-10 (IL-10) PREVENTS PRIMARY NONFUNCTION IN ALLOGENEIC ISLET TRANSPLANTATION
    CHAO, SH
    CHU, SH
    LEE, SC
    LIN, JK
    CHEN, KM
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 602 - 604
  • [42] Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease
    Huang, DR
    Zhou, YH
    Xia, SQ
    Liu, L
    Pirskanen, R
    Lefvert, AK
    JOURNAL OF NEUROIMMUNOLOGY, 1999, 94 (1-2) : 82 - 87
  • [43] Administration of Human Umbilical Cord Blood Cells Produces Interleukin-10 (IL-10) in IL-10 Deficient Mice Without Immunosuppression
    McCarthy, Brian A.
    Reddi, Alluru S.
    Coakley, Kathleen M.
    Nguyen, Steven M.
    Nayal, Rasha R.
    Javdan, Mohammad
    Paul, Santanu
    Ende, Norman
    CURRENT STEM CELL RESEARCH & THERAPY, 2010, 5 (01) : 13 - 16
  • [44] Over expression of IL-10 by macrophages overcomes resistance to murine filariasis
    Specht, Sabine
    Taylor, Matthew D.
    Hoeve, Marieke A.
    Allen, Judith E.
    Lang, Roland
    Hoerauf, Achim
    EXPERIMENTAL PARASITOLOGY, 2012, 132 (01) : 90 - 96
  • [45] VIRAL INTERLEUKIN-10 (IL-10), THE HUMAN HERPES-VIRUS-4 CELLULAR IL-10 HOMOLOG, INDUCES LOCAL ANERGY TO ALLOGENEIC AND SYNGENEIC TUMORS
    SUZUKI, T
    TAHARA, H
    NARULA, S
    MOORE, KW
    ROBBINS, PD
    LOTZE, MT
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02): : 477 - 486
  • [46] Systemic gene therapy with interleukin-10 (IL-10) for prevention of type 1 diabetes in NOD mice: Comparison of mutant (187A substitution) to recombinant murine IL-10
    Kapturczak, MH
    Wasserfall, CH
    Loiler, S
    Campbell-Thompson, M
    Scott-Jorgensen, M
    Cross, J
    Crawford, JM
    Ellis, TM
    Flotte, T
    Atkinson, MA
    MOLECULAR THERAPY, 2003, 7 (05) : S80 - S80
  • [47] Correlation between serum interleukin-6 (IL-6) and interleukin-10 (IL-10) in VLBW infants with sepsis
    P Kwinta
    Z Mitkowska
    P Kruczek
    J. J Pietrzyk
    Pediatric Research, 1999, 45 : 895 - 895
  • [48] Correlation between serum interleukin-6 (IL-6) and interleukin-10 (IL-10) in VLBW infants with sepsis
    Kwinta, P
    Mitkowska, Z
    Kruczek, P
    Pietrzyk, JJ
    PEDIATRIC RESEARCH, 1999, 45 (06) : 895 - 895
  • [49] INTERLEUKIN-10 (IL-10) MODULATES MESANGIAL CELL-PROLIFERATION AND ITS IL-6 PRODUCTION
    OSAWA, H
    YAMABE, H
    INUMA, H
    KAIZUKA, M
    TAMURA, N
    TSUNODA, S
    FUJITA, Y
    SHIRATO, K
    TAKANASHI, S
    ONODERA, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 846 - 846
  • [50] Cloning, characterisation and expression of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10).
    Gallagher, G
    Dickensheets, H
    Eskdale, J
    Izotova, LS
    Mirochnitchenko, OV
    Peat, J
    Pestka, S
    Vasquez, N
    Donnelly, RP
    Kotenko, SV
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S275 - S275